MDF has had a busy few months of activity in Washington, DC, continuing our efforts to secure research funds, engage lawmakers and make our presence known on Capitol Hill in 2019.
News
05/02/2019 - 10:46am
SAN FRANCISCO, CA (May 2, 2019): The Myotonic Dystrophy Foundation (MDF) is pleased to announce the publication of the first-ever Consensus-based Care Recommendations for Congenital and Childhood-onset Myotonic Dystrophy Type 1 and Myotonic Dystrophy Type 2.
04/23/2019 - 8:55am
Defective insulin signaling activation may underlie skeletal muscle wasting in DM1 and DM2.
04/23/2019 - 8:50am
Preclinical proof of concept is published for a small molecule strategy targeting toxic DM1 repeat-expanded RNA.
04/23/2019 - 8:45am
A recent study implicates RNAi driven by CUGexp as an independent mechanism in altered gene expression and pathogenesis of DM1.
